Cargando…
Prevalence and Impact of COVID-19 among Severe COPD Patients post Bronchoscopic Lung Volume Reduction Treatment with Endobronchial Valves
BACKGROUND: The COVID-19 pandemic has a great impact on numberless aspects of our society. In our bronchoscopic lung volume reduction interventional program, we work with severe COPD patients on a daily basis. OBJECTIVES: We were interested in the prevalence and outcome of COVID-19, impact of the pa...
Autores principales: | Klooster, Karin, Hartman, Jorine E., Koster, T. David, Slebos, Dirk-Jan, van Dijk, Marlies |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843730/ https://www.ncbi.nlm.nih.gov/pubmed/36529120 http://dx.doi.org/10.1159/000528610 |
Ejemplares similares
-
Bronchoscopic Lung Volume Reduction in Patients with Emphysema due to Alpha-1 Antitrypsin Deficiency
por: Everaerts, Stephanie, et al.
Publicado: (2023) -
Comparison of Multiple Diagnostic Tests to Measure Dynamic Hyperinflation in Patients with Severe Emphysema Treated with Endobronchial Coils
por: van Dijk, Marlies, et al.
Publicado: (2021) -
Safety and Considerations of the Anaesthetic Management during Bronchoscopic Lung Volume Reduction Treatments
por: Roodenburg, Sharyn A., et al.
Publicado: (2023) -
Long-term follow-up after bronchoscopic lung volume reduction valve treatment for emphysema
por: Hartman, Jorine E., et al.
Publicado: (2022) -
Change in Dynamic Hyperinflation After Bronchoscopic Lung Volume Reduction in Patients with Emphysema
por: van Dijk, Marlies, et al.
Publicado: (2020)